APP13007 (Clobetasol Propionate Ophthalmic Nanosuspension) for the Treatment of Inflammation and Pain after Cataract Surgery
Publication
, Conference
Levenson, J; Walters, TR; Martel, J; Wang, L; Nunez, D
Published in: INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
June 2022
Duke Scholars
Published In
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
EISSN
1552-5783
ISSN
0146-0404
Publication Date
June 2022
Volume
63
Issue
7
Related Subject Headings
- Ophthalmology & Optometry
- 3212 Ophthalmology and optometry
Citation
APA
Chicago
ICMJE
MLA
NLM
Levenson, J., Walters, T. R., Martel, J., Wang, L., & Nunez, D. (2022). APP13007 (Clobetasol Propionate Ophthalmic Nanosuspension) for the Treatment of Inflammation and Pain after Cataract Surgery. In INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (Vol. 63).
Levenson, Jeffrey, Thomas R. Walters, Joseph Martel, Laurene Wang, and Derek Nunez. “APP13007 (Clobetasol Propionate Ophthalmic Nanosuspension) for the Treatment of Inflammation and Pain after Cataract Surgery.” In INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, Vol. 63, 2022.
Levenson J, Walters TR, Martel J, Wang L, Nunez D. APP13007 (Clobetasol Propionate Ophthalmic Nanosuspension) for the Treatment of Inflammation and Pain after Cataract Surgery. In: INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE. 2022.
Levenson, Jeffrey, et al. “APP13007 (Clobetasol Propionate Ophthalmic Nanosuspension) for the Treatment of Inflammation and Pain after Cataract Surgery.” INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, vol. 63, no. 7, 2022.
Levenson J, Walters TR, Martel J, Wang L, Nunez D. APP13007 (Clobetasol Propionate Ophthalmic Nanosuspension) for the Treatment of Inflammation and Pain after Cataract Surgery. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE. 2022.
Published In
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
EISSN
1552-5783
ISSN
0146-0404
Publication Date
June 2022
Volume
63
Issue
7
Related Subject Headings
- Ophthalmology & Optometry
- 3212 Ophthalmology and optometry